抗多聚ADP核糖聚合酶(PARP)多克隆抗体
Anti-Poly ADP Ribose Polymerase (PARP) Polyclonal Antibody
PARP1; ADPRT; ADPRT1; PPOL; pADPRT-1; ADP-ribosyltransferase diphtheria toxin-like 1; NAD(+) ADP-ribosyltransferase 1
- 编号FAA279Mu01
- 物种Mus musculus (Mouse，小鼠)相同的名称，不同的物种。
- 效价-
- Ig类型IgG
- 纯化方式抗原特异性亲和纯化
- 标记物无标记物
- 激发波长-
- 单次使用量1-5 µl
- 缓冲液成份0.01M 磷酸盐缓冲液（pH7.4，containing 0.05% Proclin-300，50% glycerol）
- 性状液体
- 且适物种Homo sapiens (Human，人)
- 应用FCM
- 下载英文说明书 中文说明书
- 规格25test50test100test200test500test
- 价格¥ 720¥ 1200¥ 1920¥ 2400¥ 4200
- 欲了解实际交易价格和更多情况，请与当地经销商联系!
产品包装(模拟)
产品包装(模拟)
Human K562 cell line was fixed with 2% paraformaldehyde (10 min) , permeabilised with 0.2% BSA-Triton X-100,then stained with 20µg/ml rabbit Anti-mouse PARP Polyclonal Antibody (Catalog FAA279Mu01, red histogram) or Isotype control antibody (Catalog IS067-Rb01, green histogram), followed by 1µg/ml FITC-conjugated Anti-rabbit IgG Secondary Antibody (Catalog SAA544Rb18).
Human Hela cell line was fixed with 2% paraformaldehyde (10 min) , permeabilised with 0.2% BSA-Triton X-100,then stained with 20µg/ml rabbit Anti-mouse PARP Polyclonal Antibody (Catalog FAA279Mu01, red histogram) or Isotype control antibody (Catalog IS067-Rb01, green histogram), followed by 1µg/ml FITC-conjugated Anti-rabbit IgG Secondary Antibody (Catalog SAA544Rb18).
通过ISO 9001、ISO 13485质量体系认证
用法
For flow cytometry, the suggested use of this reagent is 1-5 µl per 10^6 cells in 100 µl volume.
Optimal working dilutions could be determined by end user.
储存
经常使用则4°C保存。-20°C保存不超过一年。避免反复冻融。
赠品
增值服务
相关产品
| 编号 | 适用物种：Mus musculus (Mouse，小鼠) | 应用(仅供研究使用，不用于临床诊断！) |
| RPA279Mu01 | 多聚ADP核糖聚合酶(PARP)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAA279Mu01 | 多聚ADP核糖聚合酶(PARP)多克隆抗体 | WB; IHC; FCM |
| FAA279Mu01 | 抗多聚ADP核糖聚合酶(PARP)多克隆抗体 | FCM |
| SEA279Mu | 多聚ADP核糖聚合酶(PARP)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMA279Mu | 多聚ADP核糖聚合酶(PARP)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. |
参考文献
| 杂志 | 参考文献 |
| ACS APPLIED BIO MATERIALS | Curcumin loaded nanostructure hybrid lipid capsules for co-eradication of breast cancer and cancer stem cells with enhanced anticancer efficacy[] |